Annual Drug Patent Expirations for ESBRIET
Esbriet is a drug marketed by Genentech Inc and is included in two NDAs. It is available from one supplier. There are twenty-one patents protecting this drug and two Paragraph IV challenges.
Drug patent litigation for ESBRIET.
This drug has two hundred and forty-three patent family members in forty-five countries.
The generic ingredient in ESBRIET is pirfenidone. One supplier is listed for this compound. Additional details are available on the pirfenidone profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
